Halozyme Therapeutics, Inc. (HALO) stock forecast — our track record

Lyra published 12 HALO stock forecasts starting on September 16, 2025. Each prediction was published before the outcome was known, and each one was later closed and scored. All 12 forecasts used the short term (0 to 3 months) horizon. The last closed window ended on June 2, 2026.

Overall, 1 forecast reached its target. No misses were recorded, and 11 forecasts ended as partial results. The average success score was 54.2%. The short term forecasts also had an average score of 54.2%, since every HALO call in this track record used that horizon. The average peak gain was 7.6%. In plain terms, most calls caught some upside, but only one reached the full target.

The best call was published on January 26, 2026. It predicted 15% growth, and HALO rose as much as 16.2%. The target was reached in 14 days, and the call scored 100%. The weakest call was published on September 22, 2025. It predicted 20% growth, while HALO rose as much as 1.1%, and the target was not reached. That call scored 50%. The record was positive overall, with many partial results and one full hit.